- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06345625
Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults (BALANCAR)
Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults - a Multisensory Approach by Use of Mixed-reality
Study Overview
Status
Conditions
Detailed Description
Older adults above 65 years old experience falls at a rate of 20-40% annually, with women being more affected than men. Unintentional falls are the second leading cause of accidental injury death and a major contributor to disability levels worldwide. Falls pose an even bigger burden on society in the future due to the increasing number of older adults and the higher prevalence of falls as people age. Gait and balance instability are major risk and causative factors for falls in older adults. As people age, their stability decreases. This is evident in the careful way that older adults walk. To prevent and predict falls, it is essential to understand how humans maintain their stability during locomotor activities.
Balance disruptions are typically not caused by walking itself, but rather by internal or external disturbances or the performance of multiple tasks simultaneously. In daily life, people often face complex situations that require high levels of sensory input and cognitive processing. This can be especially challenging when also trying to maintain a safe walking pattern, such as when checking the environment before crossing the street. This task requires coordinated movement of both the head and eyes to track moving objects. Gaze control requires accurate cognitive processing, including multisensory integration, attention, executive functioning, and motor responses to coordinate eye and head movements.
Older adults use different strategies than younger adults to control head movement for stabilizing their head during walking. Therefore, changes in head position may affect gait stability differently in older adults. Ageing can cause frailty, decline in sensorimotor and cognitive abilities, and a reduced capacity to adjust gait to changing environments. These changes may increase the risk of falls in older adults. However, research on these issues is currently insufficient.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ann Hallemans, PhD
- Phone Number: 032652912
- Email: ann.hallemans@uantwerpen.be
Study Contact Backup
- Name: Eugénie Lambrecht, MSc, PT
- Email: eugenie.lambrecht@uantwerpen.be
Study Locations
-
-
-
Antwerp, Belgium, 2160
- Recruiting
- University of Antwerp
-
Contact:
- Ann Hallemans, PhD
- Phone Number: +32 3 265 29 12
- Email: ann.hallemans@uantwerpen.be
-
Contact:
- PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Community dwelling
- an age of 65 years or above
Exclusion Criteria:
- age < 65 years
- medical history encompassing diagnosed vestibulopathy, orthostatic hypotension, peripheral neuropathy, limb amputation, neurological or neuromuscular disorders affecting balance, diagnosed neck disorders affecting sensorimotor control, blindness, deafness
- a full-time walking aid is indispensable.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Fallers
Community dwelling older adults with an age above 65 years.
A participant is categorized as faller in case of a history of ≥2 falls in the previous 12 months and with identified high fall risk on the TUG (i.e., completion time ≥13.5 seconds).
A fall is defined as an event that results in a person coming to rest inadvertently on the ground/floor/other lower level (WHO, 2021).
Asyncopal fall, identified through the report of a loss of consciousness during the fall, has a different etiology and therefore will not be counted as a fall (Ang et al., 2020).
|
Frailty will be assessed using the Fried criteria, comprising 5 categories (each accounting for 1 point if scored positive): Unintentional weight loss (interview), weakness (grip strength with hand-held dynamometer), poor endurance and energy (two statements of the CES-D Depression Scale), slowness (walking speed over 15ft through gait analysis) and low physical activity level (Minnesota Leisure Time Activity questionnaire)(Fried et al., 2001).
Markers will be placed on the predefined anatomical locations and surface electrodes for electromyography will be applied at the predefined muscle locations following the SENIAM-guidelines.
The Microsoft HoloLens 2 is fixated on the participant's head which will, on one hand, provide the cue to the participant for the head movement and on the other hand track eye and head movements.
A safety harness is attached to the body and the ceiling of the lab.
At the start of the trial, the subject will see a projection by the HoloLens 2 on the real environment moving to the left; right; upward; downward (cue in randomized order) which the participant is ought to follow with eyes and head.
First while standing still and second while walking the 10-meter overground walkway at a self-preferred walking speed.
The researcher will visit the possible participants (at their home, community centre, etc.) and after written consent on screening procedure is provided, the tests for eligibility will be performed.
Participants are followed up for 12 months.
They fill in a fall diary and telephone reminders will be performed monthly to encourage participants to complete and return their diaries.
|
|
Non-Fallers
Community dwelling older adults with an age above 65 years.
A participant is included as non-faller in case of a history of 0 falls in the previous 12 months and without an identified fall risk on the TUG test (i.e., completion time ≤13.5 seconds).
|
Frailty will be assessed using the Fried criteria, comprising 5 categories (each accounting for 1 point if scored positive): Unintentional weight loss (interview), weakness (grip strength with hand-held dynamometer), poor endurance and energy (two statements of the CES-D Depression Scale), slowness (walking speed over 15ft through gait analysis) and low physical activity level (Minnesota Leisure Time Activity questionnaire)(Fried et al., 2001).
Markers will be placed on the predefined anatomical locations and surface electrodes for electromyography will be applied at the predefined muscle locations following the SENIAM-guidelines.
The Microsoft HoloLens 2 is fixated on the participant's head which will, on one hand, provide the cue to the participant for the head movement and on the other hand track eye and head movements.
A safety harness is attached to the body and the ceiling of the lab.
At the start of the trial, the subject will see a projection by the HoloLens 2 on the real environment moving to the left; right; upward; downward (cue in randomized order) which the participant is ought to follow with eyes and head.
First while standing still and second while walking the 10-meter overground walkway at a self-preferred walking speed.
The researcher will visit the possible participants (at their home, community centre, etc.) and after written consent on screening procedure is provided, the tests for eligibility will be performed.
Participants are followed up for 12 months.
They fill in a fall diary and telephone reminders will be performed monthly to encourage participants to complete and return their diaries.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spatio-temporal parameters of gait
Time Frame: baseline
|
step length and width (cm)
|
baseline
|
|
Foot placement estimator
Time Frame: baseline
|
measure which estimates where the foot should be placed for stable gait
|
baseline
|
|
Onset latency
Time Frame: baseline
|
latency in msec between onset of movements and activation recorded by surface EMG of bilateral m.
Erector Spinae (trunk stabilization), m.
Gluteus medius (hip strategy), m.
Tibialis anterior and m.
Soleus (ankle strategy)
|
baseline
|
|
Peak amplitude
Time Frame: baseline
|
peak amplitude in microvolts of the surface EMG of bilateral m.
Erector Spinae (trunk stabilization), m.
Gluteus medius (hip strategy), m.
Tibialis anterior and m.
Soleus (ankle strategy)
|
baseline
|
|
Fixation duration
Time Frame: baseline
|
Duration of fixation of the eyes on target, measured by the Hololens 2
|
baseline
|
|
Gain
Time Frame: baseline
|
Accuracy of the fixation of the eyes on target as measured by the Hololens 2
|
baseline
|
|
Latency
Time Frame: baseline
|
Latency in msec between the movement of the target and the movement of the eyes and the head when following the target as measured by the Hololens 2.
|
baseline
|
|
Fall characteristics
Time Frame: monthly during 12 months of follow-up
|
Fall diaries provide information on occurrence and number of falls, activity preceding a fall, cause of fall, obtained injuries and potential care that was received.
|
monthly during 12 months of follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multisensory integration
Time Frame: baseline
|
reaction times in visual/sensory vs. visuo-sensory conditions (ratio, in %) measured with CatchU app
|
baseline
|
|
Digit symbol substitution test
Time Frame: baseline
|
number of correct symbol-digit pairs completed
|
baseline
|
|
Trail making test
Time Frame: baseline
|
Time to complete part A vs. B (ratio in seconds)
|
baseline
|
|
Go/No Go test
Time Frame: baseline
|
Accuracy (number of correct responses)
|
baseline
|
|
Head Repositioning Accuracy
Time Frame: baseline
|
joint position error in degrees
|
baseline
|
|
Fly test
Time Frame: baseline
|
directional accuracy (in %) of movement
|
baseline
|
|
Fly test
Time Frame: baseline
|
Amplitude (in mm) of movement
|
baseline
|
|
vHIT
Time Frame: baseline
|
VOR-gain and VOR-gain asymmetry in %
|
baseline
|
|
fHIT
Time Frame: baseline
|
statfHIT (Static visual acuity): logMAR-score and dynfHIT (Dynamic visual acuity): % correct responses
|
baseline
|
|
Frailty
Time Frame: baseline
|
Fried criteria: Frailty level (categorical): non-frail (0/5), pre-frail( 1-2/5) or frail (≥3/5)
|
baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Age
Time Frame: Screening before inclusion
|
age in years
|
Screening before inclusion
|
|
Gender
Time Frame: Screening before inclusion
|
male, female or other
|
Screening before inclusion
|
|
Medical history
Time Frame: Screening before inclusion
|
presence or absence of diagnosed vestibulopathy, orthostatic hypotension, peripheral neuropathy, limb amputation, neurological/ or neuromuscular disorders affecting balance, neck disorders affecting sensorimotor control, blindness, deafness and if a full-time walking aid is indispensable
|
Screening before inclusion
|
|
Fall history
Time Frame: Screening before inclusion
|
number of falls in last 12 months
|
Screening before inclusion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ann Hallemans, Universiteit Antwerpen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 6012 (Other)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gait
-
Centre Mutualiste de Rééducation et de Réadaptation...CompletedHealthy Volunteers | Gait | Child Development | Normal Gait | Normal Gait in Children | Pediatric Normative Gait DataFrance
-
Northumbria UniversityDANU Sports LtdRecruitingGait | Running | Walking | Gait AnalysisUnited Kingdom
-
Charles LinJewish Healthcare FoundationTerminated
-
Istanbul University - CerrahpasaCompletedGait Analysis | 3D Gait AnalysisTurkey
-
Peking University Third HospitalNot yet recruiting
-
University Hospital, GhentUniversity GhentRecruiting
-
University of NebraskaWithdrawn
-
University of PittsburghNational Institute on Aging (NIA)Completed
-
Gdansk University of Physical Education and SportNot yet recruiting
Clinical Trials on Cognition
-
University of NebraskaCompletedChronic DiseaseUnited States
-
Philips Electronics Nederland B.V. acting through...Qserve; Dent Neurologic InstituteCompleted
-
Centre Hospitalier Universitaire, AmiensTerminatedStroke | Parkinson Disease | Alzheimer Disease | Traumatic Brain Injury | Huntington Disease | Frontal DementiaFrance
-
The University of Texas at DallasYale University; University of Texas Southwestern Medical CenterCompleted
-
Centre d'Investigation Clinique et Technologique...RecruitingAssessment and Rehabilitation of Social Cognition in People With Traumatic Brain Injury (CogniSo-TC)Cognition Disorder | Head Injury TraumaFrance
-
Rush University Medical CenterRecruitingHuntington's Disease (HD)United States
-
University Hospital, ToulouseMinistry of Health, FranceRecruiting
-
Hôpital le VinatierINSERM 1028Not yet recruitingSocial Cognition | Schizophrenia Spectrum DisordersFrance
-
Université Paris CitéHopitaux de Saint-Maurice; Université Paris-SaclayRecruiting
-
University of ChicagoCompleted